Antibody response to hepatitis B immunization in infants born to HIV-infected mothers

Journal of the Medical Association of Thailand

Volumn 85, Issue 3, 2002, Pages 277-282

  Thaithumyanon, Pimolrat ^a   Praisuwanna, Pramote ^a   Ruxrungtham, Kiat ^a   Punnahitananda, Santi ^a   Thisyakorn, Usa ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Anti HBs; Hepatitis B Vaccine; HIV Infected Infants; Seroconversion

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; RECOMBINANT VACCINE;

ANTIBODY RESPONSE; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; MALE; SEROCONVERSION; VACCINATION; VIRUS HEPATITIS; VIRUS INFECTION;

FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; MALE; VACCINES, SYNTHETIC;

EID: 0036344762     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen positive mothers
2. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP)
3. Impaired response to hepatitis B vaccine in HIV infected children
4. Immunogenicity of hepatitis B vaccine in human immunodeficiency virus-infected children
5. Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus
6. Response to hepatitis B immunization by infants exposed to HIV
7. Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus
8. Update of hepatitis B prevention
9. Universal hepatitis B immunization
10. Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies
11. Prospects for control of hepatitis B virus infection: Implications of childhood vaccination and long-term protection
12. Long term efficacy of hepatitis B vaccine in infants bom to hepatitis B antigen-positive mothers
13. A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high risk Chinese neonates
14. The need for more aggressive follow-up of children bom to hepatitis B surface antigen-positive mothers: Lessons from the Louisiana perinatal hepatitis B immunization program
15. What level of hepatitis B antibody is protective?